City

Denver (1)

Houston (1)

Madrid (1)

Marseille (1)

Pamplona (1)

Condition

Myelodysplastic Syndrome Acute Myeloid Leukemia (2)

Acute Myeloid Leukemia Refractory (1)

Acute Myeloid Leukemia, in Relapse (1)

Leukemia, Myeloid, Acute (1)

Myelodysplastic Syndromes (1)

Overall Status

Recruiting (1)

Withdrawn (1)

Sign in for free

Phase

phase 1 (1)

phase 1/phase 2 (1)

Sponsor

AB Science (1)

SCRI Development Innovations, LLC (1)

Collaborator

Bristol-Myers Squibb (1)

Intervention

ab8939 (1)

azacitidine (1)

nivolumab (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (2)

myelodysplastic syndrome acute myeloid leukemia

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse, Myelodysplastic Syndrome Acute Myeloid Leukemia Trial in

Recruiting

Acute Myeloid Leukemia Refractory
+2 more

Houston, Texas
+4 more

Jun 23, 2022

Leukemia, Myeloid, Acute, MDS, Myelodysplastic Syndrome Acute Myeloid Leukemia Trial in Denver (Nivolumab)

Withdrawn

Leukemia, Myeloid, Acute
+2 more

Nivolumab

Denver, Colorado

Colorado Blood Cancer Institute

Apr 20, 2021